logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ESTRO 2019 – In melanoma patients treated with SRT+TT/IT, cumulative brain metastases volume is more prognostic than metastases number

The TOaSTT Study Group proposes a new prognostic index for survival of melanoma patients with brain metastases treated with SRT and targeted or immunotherapy